SCHEMBL24791518

SCHEMBL24791518

N#Cc1cnn2c(NCc3ccc(-c4ccccn4)cc3)cc(N[C@H]3CCNC3)nc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 6/20 0.54
▸ CDK2 P24941 7/20 0.53
▸ CDK7 P50613 5/20 0.42
▸ CDK1 P06493 3/20 0.42
▸ CCNE1 P24864 3/20 0.42
▸ CCNH P51946 3/20 0.42
▸ MNAT1 P51948 3/20 0.42
▸ CDK9 P50750 3/20 0.42
▸ CDK5 Q00535 3/20 0.42
▸ CDK4 P11802 2/20 0.42
▸ CDK6 Q00534 2/20 0.42
▸ CDK8 P49336 1/20 0.42
▸ CCNA2 P20248 2/20 0.41
▸ CHEK1 O14757 1/20 0.41
▸ CCNA1 P78396 1/20 0.41
▸ GPR39 O43194 1/20 0.41
▸ CSNK2A1 P68400 1/20 0.41
▸ DYRK3 O43781 1/20 0.40
▸ CCNT1 O60563 1/20 0.40
▸ CLK1 P49759 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24792979 0.95 CSNK2A2 (0.53) CSNK2A2CDK2CDK7CDK1CCNE1
SCHEMBL24791691 0.90 CDK2 (0.55) CSNK2A2CDK2CDK7CDK1CCNE1
SCHEMBL24791659 0.88 CDK2 (0.45) CSNK2A2CDK2CDK7CDK1CCNE1
SCHEMBL24791683 0.88 CDK2 (0.45) CSNK2A2CDK2CDK7CDK1CCNE1
SCHEMBL24791684 0.88 CDK2 (0.45) CSNK2A2CDK2CDK7CDK1CCNE1
SCHEMBL24792778 0.88 CDK2 (0.57) CSNK2A2CDK2CDK7CDK1CCNE1
SCHEMBL24792387 0.87 CDK2 (0.60) CSNK2A2CDK2CDK7CDK1CCNE1
SCHEMBL24792981 0.87 CDK2 (0.47) CSNK2A2CDK2CDK7CDK1CCNE1
SCHEMBL24791510 0.83 CDK2 (0.49) CDK2CDK7CDK1CCNE1CCNH
SCHEMBL24792971 0.83 CDK2 (0.47) CSNK2A2CDK2CDK7CDK1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117940427-A Substituted pyrazolo [1,5-a ] pyrimidine-7-amine compounds as CDK inhibitors and therapeutic uses thereof 卡里克治疗有限公司 2024-04-26 — — CN disclosed
EP-4355426-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE Carrick Therapeutics Limited (IE) 2024-04-24 — — EP disclosed
WO-2022263604-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE Carrick Therapeutics Limited (IE) 2022-12-22 — — WO disclosed
WO-2022263604-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE Carrick Therapeutics Limited (IE) 2022-12-22 — — WO disclosed
Send feedback